C-MER Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 36,000 ordinary shares on 6 July 2026 via on-market transactions at prices between HKD 0.98 and HKD 0.99 per share, for a total consideration of HKD 35,380.

Following the repurchase, the company’s issued share capital (excluding treasury shares) stands at 1.211 billion, down by 0.003%. Treasury shares increased to 21.13 million, leaving total issued shares unchanged at 1.232 billion.

The purchases were made under the general mandate approved on 20 May 2026, which authorises the company to buy back up to 123.23 million shares. To date, 36,000 shares—equivalent to 0.0029% of the share count on the mandate date—have been repurchased under this authority. A 30-day moratorium on new share issues or sales of treasury shares is in effect until 5 August 2026, in accordance with Hong Kong Stock Exchange rules.

The company confirmed that the repurchase complied with Main Board Rules and that no shares repurchased on 6 July 2026 are designated for cancellation at this time; all remain as treasury shares.